The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II trial of regorafenib as a single agent in patients with advanced and metastatic biliary tract carcinoma and first-line chemotherapy failure.
 
Anuj Kishor Patel
No Relationships to Disclose
 
Ronald G. Stoller
No Relationships to Disclose
 
John C. Rhee
No Relationships to Disclose
 
Barry C. Lembersky
Speakers' Bureau - Genentech
 
James Ohr
No Relationships to Disclose
 
James J. Lee
No Relationships to Disclose
 
Nathan Bahary
No Relationships to Disclose
 
Edward Chu
No Relationships to Disclose
 
Weijing Sun
No Relationships to Disclose